Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic
chronic pain treatment
http://tinyurl.com/5rk5ml
MARKHAM, ON, May 20 /PRNewswire-FirstCall/ - Innolife Pharma, Inc.
(Other OTC:INNP.PK - News) is pleased to announce that it has acquired
North American licensing rights to the Natural Pain Relief Center non-
narcotic proprietary breakthrough in the treatment of chronic pain.
Today, one in five americans suffer with chronic pain (~ 60 million
adults) spending approximately $120 Billion a year and the aging baby
boomers have reported in surveys more aches and pains than any
previous generation.
New Medical Finding with Brain Scans and Functional MRI's
Modern Brain Imaging has revealed that most chronic pain is the result
of the brain's inability to turn off pain messages from the body. In
chronic pain the brain simply is not producing and releasing enough
natural pain killers (such as endorphins) to stop the person's
suffering. These new medical findings show that chronic pain sufferers
from headaches, migraines, fibromyalgia, back pain, sciatica,
arthritis or a combination of all of them, are caused by a low level
of Natural Pain Killer's (such as Endorphins and others) in the brain,
as compared to people without chronic pain.
Over three years of in-clinic testing showed that this breakthrough
all-natural program relieved significant chronic pain in 8 out of 10
people and with sustainable results. This non-narcotic, combination
treatment has been receiving accolades from chronic pain sufferers
with major improvement in mood and energy and dramatic decreases in
pain levels, allowing a return to normal life function.
Innolife Pharma Inc. has an aggressive growth plan in place with a
projected target of 95 licensed clinics in 3 years with projected top
line annual revenue in excess of $30 million and a projected bottom
line profit of over $12 million annually (40+%).
With the aging demographic, chronic pain is becoming a larger and
larger international epidemic. Innolife Pharma Inc. is positioned to
be the leading service provider in this segment - with a business
model that is designed to provide excellent operating margins and
tremendous growth for many years to come.
About Innolife Pharma Inc.
Innolife Pharma Inc. (PINKSHEETS: INNP) is a small publicly traded
specialty multi-discipline medical group focusing on licensing the
Natural Pain Relief Center all-natural proprietary breakthrough in the
treatment of chronic pain.
FORWARD-LOOKING STATEMENTS:
This release contains forward-looking statements within the meaning
and pursuant to the Safe Harbor provisions of the Securities
Litigation Reform Act of 1995 and involve risks and uncertainties that
may individually or mutually impact the matters herein described,
including but not limited to product development and acceptance,
manufacturing, competition, regulatory and/or other factors, which are
outside the control of the Company.
'/>"/>
SOURCE Innolife Pharma Inc.
Copyright©2008 PR Newswire.
All rights reserved
'/>"/>
SOURCE Innolife Pharma Inc.
Copyright©2008 PR Newswire.
All rights reserved
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
ironjustice@aol.com - 30 May 2008 17:34 GMT
On May 30, 8:49 am, "ironjust...@aol.com" <ironjust...@aol.com> wrote:
endorphins <<
This would explain why marijuana .. works ..
The endorphins and cannaboid pathways seem to be related ..
Experientia. 1987 Apr 15;43(4):413-5.Links
Effect of acute administration of delta 1-tetrahydrocannabinol on beta-
endorphin levels in plasma and brain tissue of the rat.Wiegant VM,
Sweep CG, Nir I.
Acute treatment with delta 1-tetrahydrocannabinol (delta 1-THC)
elevated the concentration of beta-endorphin-like immunoreactivity
(beta-ELIR) in plasma and in the hypothalamus, but not in the
hippocampus of rats habituated to the injection procedure. These
effects were not obtained with the psychotropically inert analog of
delta 1-THC, cannabidiol. In animals that had not been habituated to
the injection procedure, placebo treatment induced a decrease in
hippocampal beta-ELIR.
PMID: 3032670 [PubMed - indexed for MEDLINE]
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://jesuswasavegetarian.7h.com
Man Is A Herbivore!
http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
> Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic
> chronic pain treatment
[quoted text clipped - 79 lines]
> DEAD PEOPLE WALKING
> http://tinyurl.com/zk9fk